Abstract
PPAR
PPAR
S. Kersten, B. Desvergne, and W. Wahli, “Roles of PPARs in health and disease,” Nature, vol. 405, no. 6785, pp. 421–424, 2000.
View at: Publisher Site | Google ScholarR. M. Evans, G. D. Barish, and Y.-X. Wang, “PPARs and the complex journey to obesity,” Nature Medicine, vol. 10, no. 4, pp. 355–361, 2004.
View at: Publisher Site | Google ScholarB. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999.
View at: Publisher Site | Google ScholarV. Bocher, I. Pineda-Torra, J.-C. Fruchart, and B. Staels, “PPARs: transcription factors controlling lipid and lipoprotein metabolism,” Annals of the New York Academy of Sciences, vol. 967, pp. 7–18, 2002.
View at: Google ScholarS. A. Smith, “Peroxisomal proliferater-activated receptors and the regulation of lipid oxidation and adipogenesis,” Biochemical Society Transactions, vol. 25, no. 4, pp. 1242–1248, 1997.
View at: Google ScholarD. Ren, T. N. Collingwood, E. J. Rebar, A. P. Wolffe, and H. S. Camp, “PPAR knockdown by engineered transcription factors: exogenous PPAR2 but not PPAR1 reactivates adipogenesis,” Genes & Development, vol. 16, no. 1, pp. 27–32, 2002.
View at: Publisher Site | Google ScholarE. D. Rosen, C.-H. Hsu, X. Wang et al., “C/EBP induces adipogenesis through PPAR: a unified pathway,” Genes & Development, vol. 16, no. 1, pp. 22–26, 2002.
View at: Publisher Site | Google ScholarE. D. Rosen and B. M. Spiegelman, “Molecular regulation of adipogenesis,” Annual Review of Cell and Developmental Biology, vol. 16, pp. 145–171, 2000.
View at: Publisher Site | Google ScholarY.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003.
View at: Publisher Site | Google ScholarY.-X. Wang, C.-L. Zhang, R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPAR,” PLoS Biology, vol. 2, no. 10, p. e294, 2004.
View at: Publisher Site | Google ScholarM. D. Leibowitz, C. Fiévet, N. Hennuyer et al., “Activation of PPAR alters lipid metabolism in db/db mice,” FEBS Letters, vol. 473, no. 3, pp. 333–336, 2000.
View at: Publisher Site | Google ScholarN. Di-Poï, N. S. Tan, L. Michalik, W. Wahli, and B. Desvergne, “Antiapoptotic role of PPAR in keratinocytes via transcriptional control of the Akt1 signaling pathway,” Molecular Cell, vol. 10, no. 4, pp. 721–733, 2002.
View at: Publisher Site | Google ScholarD. Patsouris, S. Mandard, P. J. Voshol et al., “PPAR governs glycerol metabolism,” Journal of Clinical Investigation, vol. 114, no. 1, pp. 94–103, 2004.
View at: Publisher Site | Google ScholarP. Gervois, R. Kleemann, A. Pilon et al., “Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor- activator fenofibrate,” Journal of Biological Chemistry, vol. 279, no. 16, pp. 16154–16160, 2004.
View at: Publisher Site | Google ScholarP. Delerive, J.-C. Fruchart, and B. Staels, “Peroxisome proliferator-activated receptors in inflammation control,” Journal of Endocrinology, vol. 169, no. 3, pp. 453–459, 2001.
View at: Publisher Site | Google ScholarH. Moshage, A. Casini, and C. S. Lieber, “Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes,” Hepatology, vol. 12, no. 3, part 1, pp. 511–518, 1990.
View at: Publisher Site | Google ScholarC. L. Bevins, “The Paneth cell and the innate immune response,” Current Opinion in Gastroenterology, vol. 20, no. 6, pp. 572–580, 2004.
View at: Publisher Site | Google ScholarP. R. Devchand, A. K. Hihi, M. Perroud, W.-D. Schleuning, B. M. Spiegelman, and W. Wahli, “Chemical probes that differentially modulate peroxisome proliferator-activated receptor and BLTR, nuclear and cell surface receptors for leukotriene ,” Journal of Biological Chemistry, vol. 274, no. 33, pp. 23341–23348, 1999.
View at: Publisher Site | Google ScholarD. B. Allison, X. Cui, G. P. Page, and M. Sabripour, “Microarray data analysis: from disarray to consolidation and consensus,” Nature Reviews Genetics, vol. 7, no. 1, pp. 55–65, 2006.
View at: Publisher Site | Google ScholarD. D. Hong, Y. Takahashi, M. Kushiro, and T. Ide, “Divergent effects of eicosapentaenoic and docosahexaenoic acid ethyl esters, and fish oil on hepatic fatty acid oxidation in the rat,” Biochimica et Biophysica Acta, vol. 1635, no. 1, pp. 29–36, 2003.
View at: Publisher Site | Google ScholarM. J. Coon, “Cytochrome P450: nature's most versatile biological catalyst,” Annual Review of Pharmacology and Toxicology, vol. 45, pp. 1–25, 2005.
View at: Publisher Site | Google ScholarX. Liu, M. Milo, N. D. Lawrence, and M. Rattray, “A tractable probabilistic model for Affymetrix probe-level analysis across multiple chips,” Bioinformatics, vol. 21, no. 18, pp. 3637–3644, 2005.
View at: Publisher Site | Google ScholarM. Dai, P. Wang, A. D. Boyd et al., “Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data,” Nucleic Acids Research, vol. 33, no. 20, p. e175, 2005.
View at: Publisher Site | Google ScholarS. Mandard, M. Müller, and S. Kersten, “Peroxisome proliferator-activated receptor target genes,” Cellular and Molecular Life Sciences, vol. 61, no. 4, pp. 393–416, 2004.
View at: Publisher Site | Google ScholarG. Haemmerle, R. Zimmermann, M. Hayn et al., “Hormone-sensitive lipase deficiency in mice causes diglyceride accumulation in adipose tissue, muscle, and testis,” Journal of Biological Chemistry, vol. 277, no. 7, pp. 4806–4815, 2002.
View at: Publisher Site | Google ScholarR. Zimmermann, J. G. Strauss, G. Haemmerle et al., “Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase,” Science, vol. 306, no. 5700, pp. 1383–1386, 2004.
View at: Publisher Site | Google ScholarG. Haemmerle, A. Lass, R. Zimmermann et al., “Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase,” Science, vol. 312, no. 5774, pp. 734–737, 2006.
View at: Publisher Site | Google ScholarT. Ishida, S. Choi, R. K. Kundu et al., “Endothelial lipase is a major determinant of HDL level,” Journal of Clinical Investigation, vol. 111, no. 3, pp. 347–355, 2003.
View at: Publisher Site | Google ScholarW. Jin, J. S. Millar, U. Broedl, J. M. Glick, and D. J. Rader, “Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo,” Journal of Clinical Investigation, vol. 111, no. 3, pp. 357–362, 2003.
View at: Publisher Site | Google ScholarU. C. Broedl, C. Maugeais, D. Marchadier, J. M. Glick, and D. J. Rader, “Effects of nonlipolytic ligand function of endothelial lipase on high density lipoprotein metabolism in vivo,” Journal of Biological Chemistry, vol. 278, no. 42, pp. 40688–40693, 2003.
View at: Publisher Site | Google ScholarF. E. Frerman, “Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase,” Biochemical Society Transactions, vol. 16, no. 3, pp. 416–418, 1988.
View at: Google ScholarJ. D. Beckmann and F. E. Frerman, “Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver: purification and molecular, redox, and catalytic properties,” Biochemistry, vol. 24, no. 15, pp. 3913–3921, 1985.
View at: Publisher Site | Google ScholarS. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, and W. Wahli, “Peroxisome proliferator-activated receptor mediates the adaptive response to fasting,” Journal of Clinical Investigation, vol. 103, no. 11, pp. 1489–1498, 1999.
View at: Google ScholarC. M. Jenkins, D. J. Mancuso, W. Yan, H. F. Sims, B. Gibson, and R. W. Gross, “Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase family members possessing triacylglycerol lipase and acylglycerol transacylase activities,” Journal of Biological Chemistry, vol. 279, no. 47, pp. 48968–48975, 2004.
View at: Publisher Site | Google ScholarT. C. Leone, C. J. Weinheimer, and D. P. Kelly, “A critical role for the peroxisome proliferator-activated receptor (PPAR) in the cellular fasting response: the PPAR-null mouse as a model of fatty acid oxidation disorders,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 13, pp. 7473–7478, 1999.
View at: Publisher Site | Google ScholarT. E. Akiyama, C. J. Nicol, C. Fievet et al., “Peroxisome proliferator-activated receptor- regulates lipid homeostasis, but is not associated with obesity: studies with congenic mouse lines,” Journal of Biological Chemistry, vol. 276, no. 42, pp. 39088–39093, 2001.
View at: Publisher Site | Google ScholarG. Svegliati-Baroni, C. Candelaresi, S. Saccomanno et al., “A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor- and n-3 polyunsaturated fatty acid treatment on liver injury,” American Journal of Pathology, vol. 169, no. 3, pp. 846–860, 2006.
View at: Publisher Site | Google ScholarM. M. Haluzik, Z. Lacinova, M. Dolinkova et al., “Improvement of insulin sensitivity after peroxisome proliferator-activated receptor- agonist treatment is accompanied by paradoxical increase of circulating resistin levels,” Endocrinology, vol. 147, no. 9, pp. 4517–4524, 2006.
View at: Publisher Site | Google ScholarT. Nagasawa, Y. Inada, S. Nakano et al., “Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPAR agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet,” European Journal of Pharmacology, vol. 536, no. 1-2, pp. 182–191, 2006.
View at: Publisher Site | Google ScholarY. Harano, K. Yasui, T. Toyama et al., “Fenofibrate, a peroxisome proliferator-activated receptor agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver,” Liver International, vol. 26, no. 5, pp. 613–620, 2006.
View at: Publisher Site | Google ScholarM. G. McCoy, G.-S. Sun, D. Marchadier, C. Maugeais, J. M. Glick, and D. J. Rader, “Characterization of the lipolytic activity of endothelial lipase,” Journal of Lipid Research, vol. 43, no. 6, pp. 921–929, 2002.
View at: Google ScholarM. K. Wu and D. E. Cohen, “Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice,” American Journal of Physiology, vol. 289, no. 3, pp. G456–G461, 2005.
View at: Publisher Site | Google ScholarJ. S. Bodnar, A. Chatterjee, L. W. Castellani et al., “Positional cloning of the combined hyperlipidemia gene Hyplip1,” Nature Genetics, vol. 30, no. 1, pp. 110–116, 2002.
View at: Publisher Site | Google ScholarK. L. Donnelly, M. R. Margosian, S. S. Sheth, A. J. Lusis, and E. J. Parks, “Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic mice,” Journal of Nutrition, vol. 134, no. 6, pp. 1475–1480, 2004.
View at: Google ScholarS. S. Sheth, L. W. Castellani, S. Chari et al., “Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition,” Journal of Lipid Research, vol. 46, no. 1, pp. 123–134, 2005.
View at: Publisher Site | Google Scholar